Back to Main

Faculty Detail    
Campus Address LHRB 334 Zip 0007
Phone  (205) 934-3624
Other websites

Undergraduate  Princeton University    1965  A.B. 
Medical School  Johns Hopkins University School of Medicine    1969  M.D. 
Residency  Johns Hopkins Hospital    1971  Resident, Internal Medicine 
Fellowship  University of Alabama at Birmingham    1975  Fellow in Cardiology 

Internal Medicine, American Board of Internal Medicine  1974 
Cardiovascular Disease, American Board of Internal Medicine  1975 

Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Medicine  Med - Cardiovascular Disease Professor

Biographical Sketch 
Dr Rogers received his AB degree in Biochemistry from Princeton University and MD degree from Johns Hopkins University School of Medicine. He did internal medicine residency at the Johns Hopkins Hospital, served two years in the U. S. Army Medical Corps in Vietnam and in El Paso, Texas, and then completed a fellowship in Cardiology at the University of Alabama Medical Center in 1975. He has since remained at UAB, has been Professor of Medicine since 1984 and served as Director of the Coronary Care Unit at University of Alabama Hospital for 27 years. He has been Principal Investigator for UAB for many pivotal collaborative clinical trials in cardiology including CASS, CAST, SOLVD, HERS, WISE, WAVE and multiple TIMI trials. He has been active in patient care and selected by peers on the Best Doctors in America List annually for 15 years.

Society Memberships
Organization Name Position Held Org Link
Fellow, American College of Cardiology  Governor for State of Alabama, 1985-88   
Fellow, American College of Physicians     
Fellow, Council on Clinical Cardiology of the American Heart Association  Council Representative, 1986-89; Committee on Intensive Cardiac Care 1990-93   

Research/Clinical Interest
Newer antiplatelet and antithrombin agents Impact of newer non-statin lipid modifying agents on outcome

Selected Publications 
Publication PUBMEDID
1. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, Frederick PD, Every N. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2, and 3. Journal of the American College of Cardiology 2000;36:2056-2063   
6. Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, and Zeiher AM for the ODYSSEY OUTCOMES Committees and Investigators (including Rogers WJ). Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med 2018; 379:2097-107.   
5. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, Kiefe CI, Frederick PD, Sopko G, Zheng ZJ, NRMI Investigators. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012;307:813-822.   
4. Mega JL, Hochholzer W, Frelinger AL 3rd, Kluk MJ, Angiolillo DJ, Kereiakes DJ, Isserman S, Rogers WJ, Ruff CT, Contant C, Pencina MJ, Scirica BM, Longtine JA, Michelson AD, Sabatine MS. Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. JAMA 2011;306:2221-2228.   
3. The BARI 2D Study Group (including Rogers WJ). A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.   
2. Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, Pollack CV Jr, Gore JM, Chandra-Strobos N, Peterson ED, French WJ. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008; 156:1026-34.   

Ischemic heart disease, myocardial infarction, unstable angina